Solutions for point-of-care testing
Diasfera distributes to laboratories, hospitals and point-of-care
environments in both the private and public healthcare systems.
Diasfera has developed as an international distributor of
medical diagnostics equipment – specialising in providing Point-of-Care and
end-to-end solutions for use in private and public healthcare systems. Most of
such equipment is for the diagnosis and treatment of cancers and diabetes.
Pharmaceuticals do not feature.
Diasfera has experience of a wider range of
diagnostic equipment for many other conditions – although from 2017 there has been specific focus
on point-of-care solutions for testing of diabetes and related blood testing.
Diasfera is based in the UK but operates in markets across
the Baltic and CIS region. Diasfera originally developed in countries with some
of the World’s highest levels of gastric, breast and infant cancers. For the
markets of Belarus, Lithuania and Ukraine this followed as a result of fallout
from the 1986 Chernobyl nuclear disaster.
Diasfera is now focused on investment into new laboratory testing facilities in Ukraine; and in the supply of point-of-care testing solutions into Ukraine and Lithuania.
Diasfera is now tasked to discover new opportunities that
could make best use of its success and experience across healthcare
diagnostics. Ventures that are complementary to medical diagnostics are being investigated.
Observation of National response during the COVID-19 pandemic across a number of countries has identifed the need for comprehensive supporting structures for medical diagnostics. The development of medical testing laboratory infrastructure is one area of interest. This would allow Diasfera
to offer its experience to assit the development of medical laboratories at the front-line of clinical diagnostics; and to form the necessary relationships to help form the supply chain into these laboratories.
created with
Website Builder Software .